Allam Fakhoury Selected Research

ASP9853

3/2016

ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Allam Fakhoury Research Topics

Disease

6	Overactive Urinary Bladder (Overactive Bladder) 10/2013 - 01/2009
2	Lower Urinary Tract Symptoms 10/2013 - 01/2013
2	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 10/2013 - 01/2013
2	Dizziness (Lightheadedness) 01/2013 - 12/2009
1	Pain (Aches) 11/2018
1	Lung Neoplasms (Lung Cancer) 03/2016
1	Neoplasms (Cancer) 03/2016
1	Neutropenia 03/2016
1	Urinary Retention 01/2013

Drug/Important Bio-Agent (IBA)

5	Solifenacin Succinate FDA Link 01/2013 - 01/2009
3	Tamsulosin (Flomax)FDA LinkGeneric 01/2013 - 12/2009
1	Capsaicin (Zostrix)FDA Link 11/2018
1	Pregabalin (Lyrica)FDA Link 11/2018
1	taxaneIBA 03/2016
1	Docetaxel (Taxotere)FDA Link 03/2016
1	ASP9853IBA 03/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2016
1	mirabegronIBA 10/2013
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2013
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2013
1	Muscarinic AntagonistsIBA 01/2013
1	DEET (DET)IBA 01/2013

Therapy/Procedure

2	Therapeutics 03/2016 - 10/2013